C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2004
12/22/2004	EP1487452A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n 4-methyl-3-(4-pyridin-3-yl) pyrimidin-2-ylamino) phenyl -benzamide for treating seminomas
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487447A1 Use of proton pump inhibitors for the treatment of airway disorders
12/22/2004	EP1487444A1 Use of pyridyl amides as inhibitors of angiogenesis
12/22/2004	EP1487435A1 Azetidine derivatives as ccr-3 receptor antagonists
12/22/2004	EP1487424A2 4-(4-methylpiperazin-1-ylmethyl)-n-(4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl)-benzamide for treating ang ii-mediated diseases
12/22/2004	EP1436266A4 Methods and compositions of novel triazine compounds
12/22/2004	EP1406894B1 Piperazine oxime derivatives having nk-1 receptor antagonistic activity
12/22/2004	EP0987254B1 Novel cyclic diamine compounds and medicine containing the same
12/22/2004	CN1556839A Cationic reactive dyes
12/22/2004	CN1556806A Arthropodicidal anthranilamides
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1181069C Novel inhibitors of farnesyl-protein transferase
12/22/2004	CN1181061C 2,4,5-trisubstituted imidazole compounds and its preparing process and pharmaceutical use
12/22/2004	CN1181059C Quinoline-4-base derivative I
12/22/2004	CN1181057C Novel 5-pyrimidine carboxamide derivatives and pharmaceutical compositions containing said derivatives
12/21/2004	US6833387 Chemical compounds
12/21/2004	US6833384 Deacetylase inhibitors
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833376 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
12/21/2004	US6833375 As inhibitors of the retinoic acid-metabolism, as drugs
12/21/2004	US6833370 Heterocycle substituted aminoazacycles useful as central nervous system agents
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	CA2241904C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
12/21/2004	CA2120164C Process for the preparation of aminotriazine derivatives
12/16/2004	WO2004108711A1 Pyrazinil quinazoline derivatives for use in the treatment of tumours
12/16/2004	WO2004108705A1 3-fluoro-piperidines as nmda/nr2b antagonists
12/16/2004	WO2004108704A1 Pyrimidin-4-yl 3-cyanoquinoline derivatives for use in the treatment of tumours
12/16/2004	WO2004108703A1 Pyrazinyl 3-cyanoquinoline derivatives for use in the treatment of tumours
12/16/2004	WO2004108702A1 Indole derivatives with apoptosis-inducing effect
12/16/2004	WO2004108701A1 Imidazole derivatives as glutmate receptor antagonists
12/16/2004	WO2004108700A1 Processes for preparation of polymorphic forms of desloratadine
12/16/2004	WO2004108699A1 Process for the preparation of the anti-cancer drug imatinib and its analogues
12/16/2004	WO2004108692A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108690A1 Sulphonamide compounds that modulate chemokine receptor activity (ccr4)
12/16/2004	WO2004108688A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004	WO2004108687A2 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	WO2004108686A2 Benzimidazole compounds having hypoglycemic activity
12/16/2004	WO2004108685A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	WO2004108684A1 Novel azole derivative having antifungal activity
12/16/2004	WO2004108681A1 Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin
12/16/2004	WO2004108676A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
12/16/2004	WO2004108672A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	WO2004108133A2 Modulators of vr1 receptor
12/16/2004	WO2004089882A3 Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
12/16/2004	WO2004087686A3 Benzopyran compounds useful for treating inflammatory conditions
12/16/2004	WO2004087677A3 Pyrimidin-4-one derivatives and their use as p38 kinase modulators
12/16/2004	WO2004080961A3 Crystalline and amorphous solids of pantoprazole and processes for their preparation
12/16/2004	WO2004037789A8 Methylene urea derivatives as raf-kinase inhibitors
12/16/2004	WO2002076177A3 Design and synthesis of optimized ligands for ppar
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254374 Alanyl-piperidine heterocyclic derivatives useful against cardiovascular diseases
12/16/2004	US20040254226 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/16/2004	US20040254218 Substituted piperidine compounds and methods of their use
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254215 Novel nitrogen-containing heteroaryl compounds and methods of use thereof
12/16/2004	US20040254214 7-Amido-isoindolyl compounds and their pharmaceutical uses
12/16/2004	US20040254204 Bicyclic derivatives for the treatment of abnormal cell growth
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254188 such as N-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-N'-5-isoquinolinylurea; for treating pain, inflammatory thermal hyperalgesia, urinary incontinence, or bladder overactivity
12/16/2004	US20040254186 Pyridylfurans and pyrroles as raf kinase inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254179 Central nervous system disorders; psycholgical disorders; antiepi;eptic agents; schizophrenia; Alzheimer's disease; cognition activators; analgesics
12/16/2004	US20040254178 Substituted heterocyclic compounds and methods of use
12/16/2004	US20040254177 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/16/2004	US20040254167 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/16/2004	US20040254164 3-(imidazolyl)-2-alkoxypropanoic acids
12/16/2004	US20040254159 Antiproliferative agents
12/16/2004	US20040254158 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors
12/16/2004	US20040254077 Process for producing pyridine compound
12/16/2004	CA2528924A1 Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
12/16/2004	CA2528093A1 Aryl-heteroaromatic products, compositions containing same and use thereof
12/16/2004	CA2528044A1 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
12/16/2004	CA2527814A1 Isoindolin-1-one compounds as kinase inhibitors
12/16/2004	CA2527788A1 2-(6-amino-pyridin-3-yl)-2-hydroxyethylamine derivatives as beta 2-adrenoceptors agonists
12/15/2004	EP1486550A1 Material for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486496A1 Substituted 2-(2,6-Dioxopiperidin-3-YP)-Phthalimides and 1-Oxoisoindolines and method fo reducing TNF alpha levels
12/15/2004	EP1485386A2 Pyridinyloxy derivatives as 5-ht receptor ligands
12/15/2004	EP1485379A1 Beta 3-adrenergic receptor agonists
12/15/2004	EP1485378A1 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485375A1 Pyrimidine compounds
12/15/2004	EP1485373A1 Method of stabilizing lansoprazole
12/15/2004	EP1485372A2 Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides
12/15/2004	EP1485371A2 Indole amide derivatives and their use as glycogen phosphorylase inhibitors
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485365A1 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485358A1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485348A1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase

1 ... 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 ... 1080